Omega-3 fatty acids: A review of the effects on adiponectin and leptin and potential implications for obesity management

European Journal of Clinical Nutrition

Volumn 67, Issue 12, 2013, Pages 1234-1242

  Gray, B ^a,b   Steyn, F ^b   Davies, P S W ^a,b   Vitetta, L ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

adipokines; adiponectin; leptin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; DOCOSAHEXAENOIC ACID; GLUCOSE; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; OMEGA 3 FATTY ACID; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANTIINFLAMMATORY ACTIVITY; BODY FAT; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; DIET SUPPLEMENTATION; DRUG EFFECT; FAT INTAKE; GLUCOSE METABOLISM; HORMONE RELEASE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REVIEW; RISK REDUCTION; THERAPY EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALIA;

ADIPONECTIN; ANIMALS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HEALTH PROMOTION; HUMANS; INFLAMMATION; LEPTIN; METABOLIC SYNDROME X; OBESITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84889582897     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2013.197     Document Type: Review

References (120)

1. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-1792 (Pubitemid 44033298)
2. Zhang F, Basinski M, Beals J, Briggs S, Churgay L, Clawson D et al. Human obesity protein, leptin. RCSB Protein Data Bank. Nature 1997; 387: 206-209
3. Krauss R, Eckel R, Howard B, Appel L, Daniels S, Deckelbaum R et al. AHA Dietary Guidelines Revision 2000: A statement for healthcare professionals from the nutrition committee of the American Heart Association. Circulation 2000; 102: 2284-2299
4. Meier U, Gressner A. Endocrine Regulation of Energy Metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chem 2004; 50: 1511-1525 (Pubitemid 39121218)
5. Knudson J, Dick G, Tune J. Adipokines and coronary vasomotor dysfunction. Exp Biol Med 2007; 232: 727-736 (Pubitemid 46827814)
6. Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006; 27: 2300-2309 (Pubitemid 44453573)
7. Kaidar-Person O, Person B, Szomstein S, Rosenthal R. Nutritional deficiencies in morbidly obese patients: A new form of malnutrition? Part A: Vitamins. Obes Surg 2008; 18: 870-876
8. Ren J. Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol 2004; 181: 1-10 (Pubitemid 38584659)
9. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace A et al. Adiponectin and coronary heart disease: A prospective study and meta-analysis. Circulation 2006; 114: 623-629 (Pubitemid 44252303)
10. Civitarese A, Ukropcova B, Carling S, Hulver M, DeFronzo R, Mandarino L et al. Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab 2006; 4: 75-87 (Pubitemid 43942255)
11. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731-737 (Pubitemid 34778727)
12. Dekker J, Funahashi T, Nijpels G, Pilz S, Stehouwer C, Snijder M et al. Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 2008; 93: 1489-1496 (Pubitemid 351519753)
13. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004; 90: 528-533 (Pubitemid 38530170)
14. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730-1737 (Pubitemid 38489895)
15. Considine R, Sinha V, Heiman M, Kriauciunas A, Stephens T, Nyce M et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295 (Pubitemid 26033933)
16. Frederich R, Hamann A, Anderson S, Lollmann V, Lowell B, Flier J. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314
17. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-1033 (Pubitemid 46465679)
18. Houseknecht K, Baile C, Matteri R, Spurlock M. The biology of leptin: A review. J Anim Sci 1998; 76: 1405-1420 (Pubitemid 128439681)
19. Auwerx J, Staels B. Leptin. Lancet 1998; 351: 737-742
20. Jequier E. Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci 2002; 967: 379-388 (Pubitemid 34721923)
21. Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR, Kuijper JL. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 1997; 82: 561-565 (Pubitemid 27068629)
22. Cameron AJ, Welborn TA, Zimmet PZ, Dunstan DW, Owen N, Salmon J et al. Overweight and obesity in Australia: The 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). MJA 2003; 178: 427-432 (Pubitemid 36591915)
23. Madsen E, Bruun J, Skogstrand K, Hougaard D, Christiansen T, Richelsen B. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects. Metabolism 2009; 58: 946-953
24. Jequier E. Obesity. Impairment of energy intake or of energy expenditure. Ann Endocrinol (Paris) 1995; 56: 87-92
25. Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM. Leptin prevents fastinginduced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 1997; 138: 2569-2576 (Pubitemid 27215264)
26. Friedman J, Halass J. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-777
27. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ et al. Leptin regulates proinflammatory immune responses. FASEB J 1998; 12: 57-65 (Pubitemid 28060271)
28. Shamsuzzaman AS, Winnicki M, Wolk R, Svatikova A, Phillips BG, Davison DE et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 2004; 109: 2181-2185 (Pubitemid 38625394)
29. Corsonello A, Perticone F, Malara A, De Domenico D, Loddo S, Buemi M et al. Leptin-dependent platelet aggregation in healthy, overweight and obese subjects. Int J Obes Relat Metab Disord 2003; 27: 566-573 (Pubitemid 36561013)
30. Konstantinides S, Schafer K, Loskutoff DJ. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. Ann NY Acad Sci 2001; 947: 134-141, discussion 41-2
31. Rolls B, Drewnowski A, Ledikwe J. Changing the energy density of the diet as a strategy for weight management. J Am Diet Assoc 2005; 105: S98-S103 (Pubitemid 40615762)
32. Moussavi N, Gavino V, Receveur O. Could the quality of dietary fat, and not just its quantity, be related to risk of obesity? Obesity 2008; 16: 7-15 (Pubitemid 351271943)
33. Duncan K, Bacon I, Weinsier R. The effects of high and low energy density diets on satiety, energy intake, and eating time of obese and nonobese subjects. Am J Clin Nutr 1983; 37: 763-767 (Pubitemid 13094859)
34. Johansson L, Solvoll K, Bjorneboe G, Drevon C. Under- and overreporting of energy intake related to weight status and lifestyle in a nationwide sample. Am J Clin Nutr 1998; 68: 266-274 (Pubitemid 28355642)
35. Micallef M, Munro I, Phang M, Garg M. Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Brit J Nutr 2009; 102: 1370-1374
36. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar M, Hensler M et al. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 2006; 49: 394-397 (Pubitemid 43185410)
37. Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Am Heart Assoc J 2007; 27: 1918-1925 (Pubitemid 47315642)
38. Marchioli R, Valagussa F. The results of the GISSI-Prevenzione trial in the general framework of secondary prevention. Eur Heart J 2000; 21: 949-952 (Pubitemid 30312078)
39. Ruxton C, Reed S, Simpson M, Millington K. The health benefits of omega-3 polyunsaturated fatty acids: A review of the evidence. J Hum Nutr Diet 2004; 17: 449-459 (Pubitemid 39307100)
40. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: Evaluating the risks and the benefits. JAMA 2006; 296: 1885-1899 (Pubitemid 44596197)
41. Wang Z, Al-Regaiey KA, Masternak MM, Bartke A. Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. J Ferontol Ser A Biol Sci Med Sci 2006; 61A: 323-331
42. Nahin R, Barnes P, Stussman B, Bloom B. Costs of Complementary and Alternative Medicine (CAM) and Frequency of Visits to CAM Practitioners: United States, 2007
43. US Department of Health and Human Services, Centers for Disease Control and PreventionHyattsville, USA, 2009
44. National Institutes of Health. Get the Facts: Omega-3 Supplements: An Introduction. Department of Health and Human Services: Bethesda, MD, USA, 2012
45. Mori T, Bao D, Burke V, Puddey I, Watts G, Beilin L. Dietary fish as a major component of a weight-loss diet: Effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 1999; 70: 817-825 (Pubitemid 29512906)
46. Simopoulos A. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999; 70(suppl): S560-S569
47. Simopoulos A. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21: 495-505 (Pubitemid 36026261)
48. Serhan C, Arita M, Hong S, Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirintriggered epimers. Lipids 2004; 39: 1125-1132 (Pubitemid 40129055)
49. Babcock T, Kurland A, Helton W, Rahman A, Anwar K, Espat N. Inhibition of activator protein-1 transcription factor activation by omega-3 fatty acid modulation of mitogen-activated protein kinase signaling kinases. Parenter Enteral Nutr 2003; 27: 176-180
50. Ren B, Thelen A, Peters J, Gonzalez F, Jump D. Polyunsaturated fatty acid suppression of hepatic fatty acid. Synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. J Biol Chem 1997; 272: 26827-26832 (Pubitemid 27452629)
51. Harris W, Miller M, Tighe A, Davidson M, Schaefer E. Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives. Atherosclerosis 2008; 197: 12-24
52. Morris M, Sacks F, Rosnerm B. Does fish oil lower blood pressuré A metaanalysis of controlled trials. Circulation 1993; 88: 523-533 (Pubitemid 23228051)
53. Appel L, Miller E, Seidler A, Whelton P. Does supplementation of diet with 'fish oil' reduce blood pressuré A meta-analysis of controlled clinical trials. Arch Intern Med 1993; 153: 1429-1438 (Pubitemid 23191050)
54. Harris W. n-3 Fatty acids and serum lipoproteinsHuman studies. Am J Clin Nutr 1997; 65: 1645-54S.
55. Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352: 1685-1695
56. Hotamisligil G, Arner P, Caro J, Atkinson R, Spiegelman B. Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415
57. Kressel G, Trunz B, Bub A, Hulsmann O, Wolters M, Lichtinghagen R et al. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis 2009; 202: 263-271
58. Heart Foundation Australia. Fish, fish oils, n-3 polyunsaturated fatty acids and cardiovascular health. Heart Foundation Australia 2008, [cited 25 May 2010]; Available from http://www.heartfoundation.org.au/SiteCollectionDocuments/ HW-FS-FishOils-PS-FINAL-web.pdf
59. Rizos E, Ntzani E, Bika E, Kostapanos M, Elisaf M. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 2012; 308: 1024-1033
60. Holub B. Clinical nutrition: Omega-3 fatty acids in cardiovascular care. CMAJ, 2002; 166: 608-615 (Pubitemid 34251494)
61. Jorgensen M, Bjeregaard P, Borch- Johnsen K. Diabetes and impaired glucose tolerance among the Inuit population of Greenland. Diabetes Care 2002; 25: 1766-1771 (Pubitemid 41071084)
62. Mouratoff G, Scott E. Diabetes mellitus in Eskimos after a decade. JAMA 1973; 226: 1345-1346
63. Young T, Schraer C, Shubnikoff E, Szathmary E, Nikitin Y. Prevalence of diagnosed diabetes in circumpolar indigenous populations. Int J Epidemiol 1992; 21: 730-736 (Pubitemid 23364595)
64. Burrows N, Geiss L, Engelgau M, Acton K. Prevalence of diabetes among Native Americans and Alaska Natives, 1990-1997: An increasing burden. Diabetes Care 2000; 23: 1786-1790
65. Simonsen T, Vartun A, Lyngmo V, Nordoy A. Coronary heart disease, serum lipids, platelets and dietary fish in two communities in northern Norway. Acta Med Scand 1987; 222: 237-245 (Pubitemid 18020371)
66. Adler A, Boyko E, Schraer C, Murphy N. Lower prevalence of impaired glucose tolerance and diabetes associated with daily seal oil or salmon consumption among Alaska Natives. Diab Care 1994; 17: 1498-1501 (Pubitemid 24369742)
67. Feskens E, Virtanen S, Rasanen L, Tuomilehto J, Stengard J, Pekkanen J et al. Dietary factors determining diabetes and impaired glucose tolerance: A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diab Care 1995; 18: 1104-1112
68. Hartweg J, Perera R, Montori V, Dinneen S, Neil A, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus (Review). Cochrane Database Syst Rev 2008; 1: 1-60
69. Neschen S, Morino K, Rossbacher J, Pongratz R, Cline G, Sono S et al. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptorgamma- dependent mechanism in mice. Diabetes 2006; 55: 924-928 (Pubitemid 44100165)
70. Pérez-Matute P, Pé rez-Echarri N, Marti?nez J, Marti A, Moreno-Aliaga M. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and highfat- fed rats: Role of apoptosis, adiponectin and tumour necrosis factor-a. Br J Nutr 2007; 97: 389-398 (Pubitemid 46671814)
71. Rossi AS, Lombardo YB, Lacorte JM, Chicco AG, Rouault C, Slama G et al. Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am J Physiol Regul Integr Comp Physiol 2005; 289: R486-R494 (Pubitemid 41060504)
72. Burghardt P, Kemmerer E, Buck B, Osetek A, Yan C, Koch L et al. Dietary n-3:n-6 fatty acid ratios differentially influence hormonal signature in a rodent model of metabolic syndrome relative to healthy controls. Nutr Metab 2010; 7: 1-6
73. Buettner R, Scholmerich J, Bollheimer L. High-fat diets: Modeling the metabolic disorders of human obesity in rodents. Obesity 2007; 15: 798-808 (Pubitemid 46740952)
74. Kondo K, Morino K, Nishio Y, Kondo M, Fuke T, Ugi S et al. Effects of a fish-based diet on the serum adiponectin concentration in young, non-obese, healthy Japanese subjects. J Atheroscler Thromb 2010; 17: 628-637
75. Nomura S, Shouzu A, Omoto S, Inami N, Ueba T, Urase F et al. Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes. J Atheroscler Thromb 2009; 16: 83-90
76. Gammelmark A, Madsen T, Varming K, Lundbye-Christensen S, Schmidt E. Low-dose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects. Nutr Res 2012; 32: 15-23
77. Patel JV, Lee KW, Tomson J, Dubb K, Hughes EA, Lip GY. Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction. Int J Cardiol 2007; 115: 42-45 (Pubitemid 44856752)
78. Murata M, Kaji H, Takahashi Y, Iida K, Mizuno I, Okimura Y et al. Stimulation by eicosapentaenoic acids of leptin mRNA expression and its secretion in mouse 3T3-L1 adipocytes in vitro. Biochem Biophys Res Commun 2000; 270: 343-348 (Pubitemid 30446839)
79. Perez-Matute P, Marti A, Martinez JA, Fernandez-Otero MP, Stanhope KL, Havel PJ et al. Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: Role of glucose metabolism. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1682-R1688 (Pubitemid 40720718)
80. Mori TA, Burke V, Puddey IB, Shaw JE, Beilin LJ. Effect of fish diets and weight loss on serum leptin concentration in overweight, treated-hypertensive subjects. J Hypertens 2004; 22: 1983-1990 (Pubitemid 39336682)
81. Winnicki M, Somers VK, Accurso V, Phillips BG, Puato M, Palatini P et al. Fish-rich diet, leptin, and body mass. Circulation 2002; 106: 289-291 (Pubitemid 34778948)
82. Peyron-Caso E, Taverna M, Guerre-Millo Ml, se AVr, Pacher N, Slama Gr et al. Dietary (n-3) polyunsaturated fatty acids up-regulate plasma leptin in insulinresistant rats. J Nutr 2002; 132: 2235-2240 (Pubitemid 34851656)
83. Rosicka M, Krsek M, Matoulek M, Jarkovska Z, Marek J, Justova V et al. Serum ghrelin levels in obese patients: The relationship to serum leptin levels and soluble leptin receptors levels. Physiol Res 2003; 52: 61-66 (Pubitemid 36356261)
84. Greenberg JA, Boozer CN. The leptin-fat ratio is constant, and leptin may be part of two feedback mechanisms for maintaining the body fat set point in non-obese male Fischer 344 rats. Horm Metab Res 1999; 31: 525-532 (Pubitemid 29507832)
85. Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S et al. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 2005; 115: 3579-3586 (Pubitemid 43121846)
86. Ahima R, Kelly J, Elmquist J, Flier J. Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 1999; 140: 4923-4931
87. Itariu B, Zeyda M, Hochbrugger E, Neuhofer A, Prager G, Schindler K et al. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: A randomized controlled trial. Am J Clin Nutr 2012; 96: 1137-1149
88. Koh K, Quon M, Shin K, Lim S, Lee Y, Sakuma I et al. Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia. Atherosclerosis 2012; 220: 537-544
89. Neale E, Muhlhausler B, Probst Y, Batterham M, Fernandez F, Tapsell L. Shortterm effects of fish and fish oil consumption on total and high molecular weight adiponectin levels in overweight and obese adults. Metabolism 2013; 62: 651-660
90. Yannakoulia M, Yiannakouris N, Blüher S, Matalas A, Klimis-Zacas D, Mantzoros C. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrino Metab 2003; 88: 1730-1736 (Pubitemid 36623396)
91. Yu Y, Zhu H. Chronological changes in metabolism and functions of cultured adipocytes: A hypothesis for cell aging in mature adipocytes. Am J Physiol Endocrinol Metab 2004; 286: E402-E410 (Pubitemid 38292690)
92. Koh E, Park J, Park H, Jeon M, Ryu J, Kim M et al. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 2007; 56: 2973-2981 (Pubitemid 350223632)
93. Choo H, Kim J, Kwon O, Lee C, Mun J, Han S et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 2006; 49: 784-791 (Pubitemid 43361881)
94. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 2001; 276: 41245-41254
95. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K et al. PPARg ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50: 2094-2099 (Pubitemid 33643677)
96. Karbowska J, Kochan Z. Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPARg. Biochem Pharmacol 2005; 70: 249-257 (Pubitemid 40814407)
97. van Vonderen M, van Agtmael M, Hassink E, Milinkovic A, Brinkman K, Geerlings S et al. Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss. PLoS One 2009; 4: E5647
98. Addy C, Gavrila A, Tsiodras S, Brodovicz K, Karchmer A, Mantzoros C. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrino Metab 2003; 88: 627-636 (Pubitemid 36207802)
99. Ferranti Sd, Mozaffarian D. The perfect storm: Obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008; 54: 945-955 (Pubitemid 351793400)
100. Pot G, Brouwer I, Enneman A, Rijkers G, Kampman E, Geelen A. No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: A randomized controlled trial in healthy, middle-aged individuals. Eu J Clin Nutr 2009; 63: 1353-1359
101. Lo C-J, Chiu KC, Fu M, Lo R, Helton S. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NFkB activity. J Surg Res 1999; 82: 216-221 (Pubitemid 29394126)
102. Ohata T, Fukuda K, Takahashi M, Sugimura T, Wakabayashi K. Suppression of nitric oxide production in lipopolysaccharide-stimulated macrophage cells by omega 3 polyunsaturated fatty acids. Jpn J Cancer Res 1997; 88: 234-237 (Pubitemid 27170482)
103. Khair-El-Din T, Sicher S, Vazquez M, Chung G, Stallworth K, Kitamura K et al. Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils. J Exp Med 1996; 183: 1241-1246 (Pubitemid 26113986)
104. Endres S, Ghorbani R, Kelley V, Georgilis K, Lonnemann G, van der Meer J et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-271 (Pubitemid 19045549)
105. Kremer J, Lawrence D, Jubiz W, Di Giacomo R, Rynes R, Bartholomew L et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. clinical and immunological effects. Arthritis Rheum 1990; 33: 810-820 (Pubitemid 20205760)
106. Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y. Docosahexaenoic and eisosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol 1997; 400B: 589-597
107. Endres S. n-3 Polyunsaturated fatty acids and human cytokine synthesis. Lipids 1996; 31: S239-S242
108. Meydani S, Endres S, Woods M, Goldin B, Soo C, Morrill L et al. Oral n-3 fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison in young and older women. J Nutr 1991; 121: 547-555
109. Yudkin J, Stehouwer C, Emeis J, Coppack S. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissué Arterioscler Thromb Vasc Biol 1999; 19: 972-978 (Pubitemid 29177345)
110. Esposito K, Pontillo A, DiPalo C, Giugliano G, Masella M, Marfella R et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: A randomized trial. JAMA 2003; 289: 1799-1804 (Pubitemid 37430249)
111. Gnacinska M, Magorzewicz S, Guzek M, Lysiak-Szydowska W, Sworczak K. Adipose tissue activity in relation to overweight or obesity. Endokrynol Pol 2010; 61: 160-168
112. Corica F, Allegra A, Corsonello A, Buemi M, Calapai G, Ruello A et al. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects. Int J Obes (Lond) 1999; 23: 355-360 (Pubitemid 29182393)
113. Dedoussis G, Kapiri A, Samara A, Dimitriadis D, Lambert D, Pfister M et al. Expression of inflammatory molecules and associations with BMI in children. Eur J Clin Invest 2010; 40: 388-392
114. van Dielen F, vant Veer C, Schols A, Soeters P, Buurman W, Greve J. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obesity 2001; 25: 1759-1766 (Pubitemid 33131915)
115. Zhang H, Kumar S, Barnett A, Eggo M. Tumor necrosis factor-a exerts dual effects on human adipose leptin synthesis and release. Mol Cell Endocrinol 1999; 159: 79-88 (Pubitemid 30067642)
116. Kern P, Saghizadeh M, Ong J, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss and relationship to lipoprotein lipasa. J Clin Invest 1995; 95: 2111-2119
117. Kirchgessen T, Uysal K, Wiesbrock S, Marino M, Hotamisligil G. Tumor necrosis factor-alpha contributes to obesityrelated hyperleptinemia by regulation leptin release from adipocytes. J Clin Invest 1997; 100: 2777-2782 (Pubitemid 28007546)
118. Schmidt E. Marine n-3 fatty acids and thrombosis. Thromb Res 2003; 111: 9-10 (Pubitemid 37485919)
119. Tomas E, Tsao T, Saha A, Murrey H, Zhang C, Itani S et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 2002; 99: 16309-16313 (Pubitemid 35462791)
120. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769 (Pubitemid 36735700)